SomatostatinomaSymptoms, Doctors, Treatments, Advances & More
Learn About Somatostatinoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Century Medical & Dental Center
Anzhela Dvorkina is a primary care provider, practicing in Family Medicine and Internal Medicine in Brooklyn, New York. Dr. Dvorkina is rated as an Experienced provider by MediFind in the treatment of Somatostatinoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidoses (MPS), Non-Alcoholic Fatty Liver Disease, High Cholesterol, and Obesity.
Reading Hospital Endocrinology & Diabetes Center Wyomissing
James Leu is an Endocrinologist practicing medicine in Wyomissing, Pennsylvania. Dr. Leu is rated as an Experienced provider by MediFind in the treatment of Somatostatinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Hyperthyroidism, Thyroid Storm, Hypothyroidism, and Hyperparathyroidism. Dr. Leu is board certified in American Board Of Internal Medicine.
Tufts Medical Center
Ronald Lechan is an Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Lechan is rated as a Distinguished provider by MediFind in the treatment of Somatostatinoma. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Prolactinoma, Cockayne Syndrome, and Hypoparathyroidism-Intellectual Disability-Dysmorphism Syndrome.
Summary: RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Summary: The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider (HCP)-assessed ECOG performance status and overall survival. The purpose is to advance the evidence-base for incorporating objective assessment of Physical Activity (PA) in the context of performance status assessment in...